ONKI3 | Medical Subject Headings

The ONKI is provided as a part of the ONKI Living Lab - an open lab for testing the latest semantic web technologies in practice, with real users like you. Currently, over 10 000 people are using ONKI each month.

We hope you like the ONKI service and enjoy using it for your purposes!

If you encounter any problems or have improvement ideas, please contact the ONKI team. We are also very much interested in your success stories in using ONKI - please share your experiences!

The ONKI Team

Jouni Tuominen, Living Lab contact person, APIs, widgets, publishing of ontologies, etc.
Eero Hyvönen, professor, head of research group

Former members: Kim Viljanen, Rami Alatalo.

Building the future of the Semantic Web and beyond.

SeCo's homepage
For the latest semantic news, follow us on Twitter and fan us on Facebook!

How can we help you?

Live presentations about ONKI: what it is? how to use it?
Support for creating and publishing ontologies.
Online technical support for using ONKI.
Co-operation in projects.
And more, please ask.

suomeksi på svenska in English

The way property values are displayed: value/row values side by side

The way concept relations are shown: separately in hierarchy

Cardiotonic Agents

Loading results...


Hierarchy:	Medical Subject Headings (MeSH) ∟ Chemical Actions and Uses ∟ Pharmacologic Actions ∟ Physiological Effects of Drugs ∟ Protective Agents ∟ Cardiotonic Agents 19 coordinate concepts ∟ Antidotes \| ∟ Antimutagenic Agents \| ∟ Antioxidants \| ∟ Cariostatic Agents \| ∟ Cryoprotective Agents \| ∟ Neuroprotective Agents \| ∟ Radiation-Protective Agents \| ∟ Anti-Arrhythmia Agents \| ∟ Antihypertensive Agents \| ∟ Calcium Channel Blockers \| ∟ Cardioplegic Solutions \| ∟ Fibrinolytic Agents \| ∟ Natriuretic Agents \| ∟ Nitric Oxide Donors \| ∟ Potassium Channel Blockers \| ∟ Sclerosing Solutions \| ∟ Sodium Channel Blockers \| ∟ Vasoconstrictor Agents \| ∟ Vasodilator Agents Medical Subject Headings (MeSH) ∟ Chemical Actions and Uses ∟ Pharmacologic Actions ∟ Therapeutic Uses ∟ Cardiovascular Agents ∟ Cardiotonic Agents 19 coordinate concepts ∟ Antidotes \| ∟ Antimutagenic Agents \| ∟ Antioxidants \| ∟ Cariostatic Agents \| ∟ Cryoprotective Agents \| ∟ Neuroprotective Agents \| ∟ Radiation-Protective Agents \| ∟ Anti-Arrhythmia Agents \| ∟ Antihypertensive Agents \| ∟ Calcium Channel Blockers \| ∟ Cardioplegic Solutions \| ∟ Fibrinolytic Agents \| ∟ Natriuretic Agents \| ∟ Nitric Oxide Donors \| ∟ Potassium Channel Blockers \| ∟ Sclerosing Solutions \| ∟ Sodium Channel Blockers \| ∟ Vasoconstrictor Agents \| ∟ Vasodilator Agents Medical Subject Headings (MeSH) ∟ Chemical Actions and Uses ∟ Specialty Uses of Chemicals ∟ Protective Agents ∟ Cardiotonic Agents 19 coordinate concepts ∟ Antidotes \| ∟ Antimutagenic Agents \| ∟ Antioxidants \| ∟ Cariostatic Agents \| ∟ Cryoprotective Agents \| ∟ Neuroprotective Agents \| ∟ Radiation-Protective Agents \| ∟ Anti-Arrhythmia Agents \| ∟ Antihypertensive Agents \| ∟ Calcium Channel Blockers \| ∟ Cardioplegic Solutions \| ∟ Fibrinolytic Agents \| ∟ Natriuretic Agents \| ∟ Nitric Oxide Donors \| ∟ Potassium Channel Blockers \| ∟ Sclerosing Solutions \| ∟ Sodium Channel Blockers \| ∟ Vasoconstrictor Agents \| ∟ Vasodilator Agents X
Broader terms:	Medical Subject Headings (MeSH) ∟ Chemical Actions and Uses ∟ Pharmacologic Actions ∟ Physiological Effects of Drugs ∟ Protective Agents ∟ Cardiotonic Agents Medical Subject Headings (MeSH) ∟ Chemical Actions and Uses ∟ Pharmacologic Actions ∟ Therapeutic Uses ∟ Cardiovascular Agents ∟ Cardiotonic Agents Medical Subject Headings (MeSH) ∟ Chemical Actions and Uses ∟ Specialty Uses of Chemicals ∟ Protective Agents ∟ Cardiotonic Agents Protective Agents > Physiological Effects of Drugs > Pharmacologic Actions > Chemical Actions and Uses > Medical Subject Headings (MeSH) Cardiovascular Agents > Therapeutic Uses > Pharmacologic Actions > Chemical Actions and Uses > Medical Subject Headings (MeSH) Protective Agents > Specialty Uses of Chemicals > Chemical Actions and Uses > Medical Subject Headings (MeSH) X
History note:	Cardiac Glycosides (1966-1979) \| specific drug or agent (1966-1979) \| Sympathomimetics (1966-1979)X
historyNote*:	80 X
publicMeSHNote*:	80 X
Scope note:	Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE, CONGESTIVE). X
activeMeSHYear*:	2006 \| 2006A \| 2007X
dateCreated*:	1979-02-28X
dateEstablished*:	1980-01-01X
dateRevised*:	2005-07-11X
recordAuthorizer*:	agsX
recordMaintainer*:	agsX
recordOriginator*:	SHX
Type:	Concept X
Coordinate terms:	Antidotes \| Antimutagenic Agents \| Antioxidants \| Cariostatic Agents \| Cryoprotective Agents \| Neuroprotective Agents \| Radiation-Protective Agents \| Anti-Arrhythmia Agents \| Antihypertensive Agents \| Calcium Channel Blockers \| Cardioplegic Solutions \| Fibrinolytic Agents \| Natriuretic Agents \| Nitric Oxide Donors \| Potassium Channel Blockers \| Sclerosing Solutions \| Sodium Channel Blockers \| Vasoconstrictor Agents \| Vasodilator Agents X
URI:	X
Labels and equivalent concepts:	Sydämen toimintaa tehostavat lääkkeet (fi) Inotrooppiset lääkkeet (fi, replaced) Inotrooppinen lääkitys (fi, replaced) Kardiotooninen lääke (fi, replaced) Kardiotooninen lääkitys (fi, replaced) Sydämen toimintaa tehostava lääke (fi, replaced) Kardiotooniset lääkkeet (fi, replaced) Inotrooppinen lääke (fi, replaced) Inotrooppi (fi, replaced) Inotroopit (fi, replaced) Hjärtstimulerande medel (sv) Cardiotonic Drugs (en, replaced) Cardioprotective Agents (en, replaced) Cardiotonics (en, replaced) Inotropic Agents, Positive Cardiac (en, replaced) Myocardial Stimulants (en, replaced) Cardiac Stimulants (en, replaced) X
Share:	X